Longeveron initiates phase 2b stem cell therapy trial to treat ageing frailty
Longeveron LLC, a regenerative medicine company developing cellular therapies, announced that it treated its first patient in the Company’s Phase 2b clinical trial evaluating the safety and efficacy of Longeveron...
Read More